BRCA1 transcriptional activity is enhanced by interactions between its AD1 domain and AhR

Cancer Chemother Pharmacol. 2008 Nov;62(6):965-75. doi: 10.1007/s00280-008-0686-x. Epub 2008 Feb 8.

Abstract

Purpose: We previously reported that BRCA1 interacts with aryl hydrocarbon receptor nuclear translocator (ARNT) and that this interaction affects TCDD-induced CYP1A1 gene expression (Kang et al., J Biol Chem 281:14654-14662, 2006). In this study we continue this investigation and begin to define the significance of this interaction for the regulation of stress-induced transcription.

Methods: Immunoprecipitations (IPs), western blot (WB) analysis, GST pull-down assays and promoter reporter assays were used to investigate whether the aryl hydrocarbon receptor (AhR) can regulate transcription that is dependent on the activation domain 1 (AD1) domain of BRCA1.

Results: We show that AhR, a transcription factor, can bind specifically to AD1 in the C-terminal region of BRCA1 and affect BRCA1's ability to regulate transcription activity. We found that xenobiotics that positively and negatively affect AhR's activity as a transcription factor (e.g., dioxin and alpha-naphthoflavone, respectively), have similar effects on AhR's ability to affect AD1-domain-dependent transcription. These physical and functional AhR-AD1 interactions may require the coiled-coil motif in AD1 because point-mutations in this motif reduce these interactions.

Conclusion: Xenobiotic-activated AhR can function in two ways, as a component of the AhR/ARNT transcription factor and a regulator of AD1-dependent transcription. Consequently, BRCA1 has two distinct mechanisms for sensing xenobiotics and regulating AhR-dependent stress responses to these xenobiotics. We speculate that the normal functioning of this interaction could play a role in BRCA1's tumor suppressing ability.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • BRCA1 Protein / chemistry*
  • BRCA1 Protein / pharmacology
  • Benzoflavones / pharmacology
  • Binding, Competitive
  • Cell Line, Tumor / metabolism
  • Gene Expression Regulation, Neoplastic / drug effects
  • Gene Expression Regulation, Neoplastic / physiology*
  • Genes, Reporter
  • Humans
  • Neoplasm Proteins / chemistry*
  • Neoplasm Proteins / pharmacology
  • Polychlorinated Dibenzodioxins / pharmacology
  • Protein Binding
  • Protein Interaction Mapping
  • Protein Structure, Tertiary
  • Proto-Oncogene Proteins c-jun / metabolism
  • Receptors, Aryl Hydrocarbon / chemistry*
  • Receptors, Aryl Hydrocarbon / drug effects
  • Transcription, Genetic / drug effects
  • Transcription, Genetic / physiology*

Substances

  • BRCA1 Protein
  • BRCA1 protein, human
  • Benzoflavones
  • Neoplasm Proteins
  • Polychlorinated Dibenzodioxins
  • Proto-Oncogene Proteins c-jun
  • Receptors, Aryl Hydrocarbon
  • alpha-naphthoflavone